U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07327944) titled 'Relapse Management Group Psychoeducation Program' on Dec. 26, 2025.
Brief Summary: This study was planned to be conducted between February and March 2026, with a total of 60 patients diagnosed with schizophrenia who met the inclusion criteria and were followed at the community mental health center in the Psychiatry Building of Ankara Etlik City Hospital. 30 patients were in the experimental group and 30 were in the control group.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Relapse Management
Intervention:
OTHER: Relapse Management Group Psychoeducation Program
Schizophrenia patients in the experimental grou...